Skip to main content
OpenTrials
Completed

NCT Number: NCT05663645

Navigating Health Insurance Selection for IVF Benefits

The purpose of this study is to evaluate the effectiveness of an educational intervention on health insurance literacy and utilization of in vitro fertilization (IVF) insurance benefits. The investigators hypothesize that the intervention is acceptable and satisfactory and will result in increased health insurance literacy and utilization of IVF benefits.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infertility Genital Diseases Urogenital Diseases

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of California San Diego

La Jolla, California, 92093, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Employees eligible for health insurance coverage
  • Reproductive aged (18 to 50 years)
  • Intention to grow their family in the next year
  • Primary language English or Spanish

Exclusion criteria

  • None

Treatment and study plan

Health insurance educational guide

Behavioral

The educational guide includes 4 content areas: 1) Definition of key insurance terms; 2) premiums, deductibles across the five 2023 health plans; 3) Summary of how premiums and deductibles can affect out of pocket costs; 4) Guide to finding in-network IVF providers and facilities.

Primary outcomes

  1. Health Insurance Literacy Measure

    Time frame: 10 months after receipt of the intervention

    9 items from the Health Insurance Literacy Measure will assess participants' confidence using their health insurance and being proactive with their health insurance for IVF services. Items will be scored from 0 (not at all confident) to 3 (very confident). Higher scores indicate better health insurance literacy.

Secondary outcomes

  1. Health Insurance Literacy Measure

    Time frame: 1 month after receipt of the intervention

    6 items from the Health Insurance Literacy Measure will assess participants' likelihood of comparing health insurance plans. Items will be scored from 0 (not at all confident) to 3 (very confident). Higher scores indicate better health insurance literacy.

  2. Utilization of IVF services

    Time frame: 10 months after receipt of the intervention

    Participants will self-report utilization of IVF services.

  3. Insurance coverage

    Time frame: 10 months after receipt of the intervention

    Participants will self-report insurance coverage related to IVF services.

  4. Out of pocket expenses

    Time frame: 10 months after receipt of the intervention

    Participants will self-report out-of-pocket expenses related to IVF services.

  5. Financial hardship

    Time frame: 10 months after receipt of the intervention

    The 15-item Economic Strain and Resilience in Cancer tool will be used as a self-report subjective measure of financial hardship related to infertility and IVF services. Items are scored from 0 (least hardship) to 10 (most severe hardship). Higher scores indicate worse financial hardship.

Sponsors and collaborators

Lead sponsor

University of California, San Diego

Other

Registry information

Official study title

Navigating Health Insurance Selection for in Vitro Fertilization (IVF) Benefits

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Dec 23, 2022
Registry last updated
Oct 30, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.